Claim OwnershipTrends from the Trenches
Subscribed: 6Played: 49
Subscribe
© 2024 Trends from the Trenches
Description
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
30 Episodes
Reverse
Tune into this month’s episode of Trends from the Trenches, where host Stan Gloss and Ruth Marinshaw, CTO of Research Computing at Stanford University, talk about the accomplishments and challenges of supporting a diverse population of researchers in academia. Marinshaw also delves into building a reliable and trustworthy service, computational infrastructure as an essential tool for the lab, what FAIR data means to her at Stanford, and her thoughts on AI and its impact. Trends fro...
In this special episode of the Trends from the Trenches podcast, listen in on the Trends from the Trenches session at this year’s Bio-IT World Conference & Expo. Ari Berman, PhD, CEO of BioTeam, delivers a candid talk about the technologies driving data-intensive science, from the most worthwhile to the most overhyped to the most relevant. Learn what’s happening now with computing, storage, data transfer, networks, cloud, data science, machine learning, and more. Trends ...
In this month’s episode of Trends from the Trenches, host Stan Gloss speaks with Joseph La Barge. La Barge trained as an attorney but has spent most of his career building biotech businesses and securing funding. He shepherded Spark Therapeutics through its acquisition by Roche and has since joined Apertura Gene Therapy as CEO. He and Stan talk about the entrepreneurship journey, gene expression and capsid engineering, and Apertura’s future goals and projects. Links from this episode: &...
Change can be scary, but it can also bring new opportunities and lead to growth and innovation. In this episode of Trends from the Trenches, host Stan Gloss from BioTeam and Adama Ibrahim, VP of Digital Strategy & Change Management at Novo Nordisk, delve into a conversation about humanity’s natural resistance to change, why it is important to overcome that resistance, and how change is the key to making progress. Ibrahim also shares how Novo Nordisk is supporting research organizations th...
It’s no secret that the industry is drowning in data. That’s why data management strategies are needed now more than ever to speed up discoveries and bring new solutions to the market. In this episode of Trends from the Trenches, host Stan Gloss discusses data management strategies with Becky Upton, Ph. D., President of Pistoia Alliance. Dr. Upton shares how her organization is maximizing data management efficiency, such as delivering data at scale and harnessing AI to expedite R&D, and h...
Going from one field to the next can be a tricky thing to navigate. In this episode of Trends from the Trenches, host Stan Gloss speaks with Tom Miller, Co-Founder and CEO of Iambic Therapeutics, about his journey from academia as a professor at the California Institute of Technology to getting B-Round funding as the CEO of his own start-up. Miller discusses why he started his company, what inspired him to turn his research into an entrepreneurial venture, and how combining physics and data c...
In this episode of Trends from the Trenches, host Stan Gloss speaks with Heidi Rehm, PhD, Chair Elect of the Global Alliance for Genomics and Health (GA4GH), about data sharing policies and standards that can advance both genomics and health. Rehm discusses the benefits of data sharing on a global scale, how organizations can reduce friction of people’s usage and adoption of standards, and successful examples of implementation. She also shares her thoughts on the future of AI, “data citizensh...
In the latest episode of the Trends from the Trenches podcast, host Stan Gloss and Bryn Roberts, PhD, Global Head of Data & Analytics at Roche Information Solutions explore the Why and the How behind AI. What used to be “happily left a bit in the background” is now main stage thanks to everyone’s new interest in ChatGPT. Roberts recommends applying pharma’s Target Product Profiles (TPPs) to AI products as well: understanding what a tool or model should do, who its users are, how it will b...
After the “magical moment of hope” when the first human genome was sequenced, Jeanne Kehren switched from veterinary medicine to the pharmaceutical industry. Today, she is the SVP of Digital & Commercial Innovation and CIO at Bayer Pharmaceuticals and works in various areas, including sustainability, digital health, and digital transformation. In this episode of Trends from the Trenches, host Stan Gloss speaks with Kehren about what drew her to pharmaceuticals, the potential future of dig...
A few years ago, artificial intelligence was in its developmental stages. Today, it is widely used by various industries and several companies are exploring new ways to utilize its tremendous potential. In this episode of Trends from the Trenches, Stan Gloss speaks with Jarrod Anderson, Senior Director of Artificial Intelligence at ADM, who discusses prioritizing projects, selecting the best team members, and overcoming the biggest challenges that companies encounter in the machine learning s...
In this episode of Trends from the Trenches, Stan Gloss speaks with Efosa Ojomo, director of the Global Prosperity Group at the Clayton Christensen Institute (CCI) and coauthor of The Prosperity Paradox: How Innovation Can Lift Nations Out of Poverty, about the parallels between consumption economy and life sciences research. Ojomo discusses how relying on data metrics does not necessarily provide full insight on what a consumer audience needs, why it is important to also look at non-consumer...
Bryn Roberts has spent thirty years in informatics and data, most recently at Roche and before that at AstraZeneca. Now as Global Head of Data and Analytics at Roche Information Solutions, Roberts applies his career-long learnings to the current era of data in life sciences, offering advice for building data citizenship, creating a FAIR data culture, and avoiding vendor lock-in. Links from this episode: Bryn Roberts: Reflections on Pharma’s Scientific Computing Journey Bio-IT Worl...
At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson lists the areas at Pfizer where AI is in play and for which she has AI/ML responsibility: research and discovery, clinical development, manufacturing supply chain, commercial, medical affairs, human resources, financial departments, and more. Pfizer ...
Kjiersten Fagnan is an applied mathematician enamored of biology’s messy datasets. Now, as chief informatics officer at the Department of Energy Joint Genome Institute (JGI), located at Lawrence Berkeley National Laboratory, she finds bioinformatics' computational and data challenges very different from applied math or partial differential equations. Fagnan is the newest guest on the Trends from the Trenches podcast, speaking with host Stan Gloss of BioTeam about JGI’s Genome Citation Service...
The steel industry is not a common birthplace of biotech companies, but Andrew Hopkins traces the ideas that became Exscientia back to his time there. New technologies and new processes replaced nearly 90% of the steel workforce, and Hopkins kept those market lessons. He says, “When I ended up in pharma and biotech, I had a very different perception of the power of commerce and markets and what they can potentially drive, and the power of new technology to position oneself in those markets.” ...
After ten years of working on a specific disease, Chris Gibson’s graduate school lab tested their treatment theory on an animal model. It not only didn’t work, it actually made the animals worse. The experience prompted Gibson to look into how other tools and techniques could be brought to bear on biological programs. And so he quit medical school to co-found Recursion Pharmaceuticals where he is now CEO. In this episode, Gibson sits down with host Stan Gloss of BioTeam, about Recursion...
Terry Lo has been in healthcare for almost 25 years, with business and commercial roles across pharma, diagnostics, and life sciences, but his most recent role—CEO at Vizgen—connects him with what he calls, “without a doubt the most exciting space I’ve been involved with.” In this episode, Lo speaks with BioTeam’s Stan Gloss about spatial biology, why it matters, and how he imagines the technology changing healthcare’s future. Lo details how a science that explores the intersections bet...
Host Stan Gloss, founder of BioTeam, talks with Aaron Friedman, HealthAI Principal Product Manager at Amazon Web Services, about the launch of Amazon Omics. This new purpose-built service helps healthcare and life science organizations store, query, and analyze genomic, transcriptomic, and other omics data to generate insights that improve health and advance scientific discoveries. The platform simplifies and accelerates the process of storing and analyzing data for research and clinical appl...
Host Stan Gloss, founder of BioTeam, invites Mike Tarselli, chief scientific officer at TetraScience, to chat about data and how the life sciences industry thinks about our primary product. They discuss the tech sector’s influence on pharma in switching from a project mindset that yields outputs to a product mindset that yields outcomes and why the industry should use traditional supply chain mechanics as the blueprint to generate and package data. Tarselli also advises biotech companies...
Graphene has quickly become a biotech buzzword as scientists aim to better connect with biology and usher in a new wave of technological advancements. Outperforming silicon at nearly every turn, graphene is one of the most biocompatible tools for extracting valuable information without disrupting biological systems. “Graphene is a single layer of carbon molecules. Everything in our body is made of carbon. It’s the most compatible material we can find that has amazing electronic properties. Yo...
Comments
Download from Google Play
Download from App Store
United States